Nordic Nanovector To Present At The Carnegie Healthcare Seminar On 17 March 2016
OSLO, Norway--(BUSINESS WIRE)--Nordic Nanovector ASA (OSE:NANO), a company focusing on the development and commercialisation of novel targeted therapeutics in haematology and oncology announces that Marco Renoldi, Chief Business Officer, will hold a company presentation at the Carnegie Healthcare Seminar in Stockholm on Thursday 17 March 2016.